COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 355: Articles 3541-3550  | Next

New design strategies for ultra-specific CRISPR-Cas13a-based RNA-diagnostic tools with single-nucleotide mismatch sensitivity
Molina Vargas, A. M., Osborn, R. M., Sinha, S., Arantes, P. R., Patel, A., Dewhurst, S., Palermo, G., O'Connell, M. R.
10.1101/2023.07.26.550755 — Posted: 2023-07-28
Butyrate Protects against SARS-CoV-2-induced Tissue Damage in Golden Hamsters.
Yu, H., Yuan, L., Yan, Z., Zhou, M., Ye, J., Wu, K., Chen, W., Chen, R., Xia, N.-S., Guan, Y., Zhu, H.
10.1101/2023.07.27.550811 — Posted: 2023-07-28
Mapping immunological and host receptor binding determinants of SARS-CoV spike protein utilizing the Qubevirus platform
Bopda Waffo, A.
10.1101/2023.07.27.550841 — Posted: 2023-07-28
Multiscale modelling of chromatin 4D organization in SARS-CoV-2 infected cells
Chiariello, A. M., Abraham, A., Bianco, S., Esposito, A., Vercellone, F., Conte, M., Fontana, A., Nicodemi, M.
10.1101/2023.07.27.550709 — Posted: 2023-07-28
Chronic Shedding of a SARS-CoV-2 Alpha Variant Lineage Q.3/Q.4 in Wastewater
Conway, M. J., Yang, H., Revord, L. A., Ward, A. S., Abel, J. D., Williams, M. R., Uzarski, R. L., Alm, E. W.
10.1101/2023.07.26.23293191 — Posted: 2023-07-27
Asymmetry in the peak in Covid-19 daily cases and the pandemic R-parameter
Bhatkar, S., Ma, M., Tarafder, A., Doniach, S., Bhanot, G.
10.1101/2023.07.23.23292960 — Posted: 2023-07-27
KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution
Reis de Andrade, J., Scourfield, E., Peswani-Sajnani, S., Poulton, K., Ap Rees, T., Khooshmehri, P., Doherty, G., Ong, S., Ivan, I., Goudarzi, N., Gardiner, I., Caine, E., Maguire, T. J. A., Leightley, D., Torrico, L., Gasulla, A., Tan, A. V. F., Griffin, A., Papaioannou, S., Trouillet, C., Mischo, H., Giralt, V., Wilson, S., Kirk, M., Martindale, J., Curtis, C., Zuckerman, M., Razavi, R., Malim, M. H., Martinez-Nunez, R. T.
10.1101/2023.07.25.23293154 — Posted: 2023-07-27
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk patients with COVID-19 in North West London: aretrospective cohort study using the Discover dataset
Drysdale, M., Galimov, E. R., Yarwood, M. J., Patel, V., Levick, B., Gibbons, D. C., Watkins, J. D., Young, S., Pierce, B. F., Lloyd, E. J., Kerr, W., Birch, H. J., Kamalati, T., Brett, S. J.
10.1101/2023.07.26.23293188 — Posted: 2023-07-27
The Cost of Keeping Patients Waiting: Retrospective Treatment-Control Study of Additional Healthcare Utilisation for UK Patients Awaiting Elective Treatment Following COVID-19
James, C., Denholm, R., Wood, R. M.
10.1101/2023.07.25.23293143 — Posted: 2023-07-27
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents
Jay, C., Adland, E., Csala, A., Lim, N., Longet, S., Ogbe, A., Ratcliff, J., Sampson, O., Thompson, C., Turtle, L., Barnes, E., Dunachie, S., Klenerman, P., Carroll, M., Goulder, P.
10.1101/2023.07.24.23293091 — Posted: 2023-07-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).